miR-34B-5P inhibitor
miR-34B-5P inhibitor has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Sep 16, 2024: “Low frequency sinusoidal electromagnetic fields promote the osteogenic differentiation of rat bone marrow mesenchymal stem cells by modulating miR-34b-5p/STAC2”.
1 paper studies it1 findingUpdated
See all 1 papers on miR-34B-5P inhibitor
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: Department of Science and Technology, Hubei Provincial People's Government and 3 more
- Animals1
What did studies of miR-34B-5P inhibitor find?
1Studies of miR-34B-5P inhibitor measured one outcome, bone mass loss.
Bone mass loss
downin rats1
1 study
Bone mass loss
downin rats1
miR-34B-5P inhibitor decreases bone mass loss in rats (ovariectomized rats).
“miR-34b-5p inhibitor injections alleviate bone mass loss and trabecular microstructure deterioration in ovariectomy (OVX) rats.”
Animalsovariectomized ratsbone
Communications biology